Radar · Life Sciences Tech in London
Best Life Sciences Tech Companies in London, United Kingdom
The 169 best Life Sciences Tech companies in London, United Kingdom in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Isomorphic Labs.
By Riya SenguptaFinancials
169companies tracked
$3.9Bdisclosed funding
0unicorns
82have raised
FLIAR INTELLIGENCE · LIFE SCIENCES TECH × LONDON
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
50companies analysed
89%cloud-native stacks
2025funding peak (by rounds)
8unicorns
2018median founding year
444kcombined LinkedIn audience
44%of audience held by top 3
3companies hiring publicly (12 mo)
Ranked: Best Life Sciences Tech companies in London
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Isomorphic Labs Digital platform focused on revolutionizing drug discovery using AI 60Funding top 12%AI top 20%Innovation top 30%Patents top 33% All 11 signals ▾Fundingtop 12% AItop 20% Innovationtop 30% Patentstop 33% Moattop 39% Talentbottom 49% Growthbottom 47% Techbottom 46% Globalbottom 37% Marketbottom 36% Newsbottom 25% Funding: Raised $2.7B across 2 rounds · 2 rounds over 1 yrs (2.0/yr) AI: Classified as an AI company rank vs industry peers · Fliar Intelligence Index 60/100 | $2.7B | 1 mo ago | Series B | — | Demis Hassabis Founder & CEO | WebflowThree.jsGSAP+14 | 19 patents AI-driven drug discovery: protein‑ligand modeling, molecule property prediction, synthesis feasibility. | — |
| 2 | Genomics Provider of genomic risk assessment and prevention platform 64Patents top 19%Innovation top 24%Funding top 24%Talent top 28% All 9 signals ▾Patentstop 19% Innovationtop 24% Fundingtop 24% Talenttop 28% Moattop 32% Growthtop 45% Globaltop 46% Techtop 50% Marketbottom 40% Patents: 48 patents matched (strict assignee match) · 33 filings since 2022 vs 13 in 2017-21 Innovation: 48 patents (top 22% of patent-holders) · 33 filings since 2022 vs 13 in 2017-21 rank vs industry peers · Fliar Intelligence Index 64/100 | $161M | 29 mo ago | Series C | — | Rebecca H Founder & Principal | HubSpot CMS HubApple iCloud Mailcore-js+14 | 48 patents Software platforms for computational analysis of genomic sequencing data | — |
| 3 | Automata Developer of modular lab automation platforms for biological research workflows 64Funding top 25%Product top 25%Tech top 27%Moat top 31% All 11 signals ▾Fundingtop 25% Producttop 25% Techtop 27% Moattop 31% Innovationtop 32% Fin. healthtop 33% Newstop 43% Growthtop 48% Talentbottom 49% Marketbottom 44% Globalbottom 39% Funding: Raised $107M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) Product: 7 distinct product lines · Company stage: Series C rank vs industry peers · Fliar Intelligence Index 64/100 | $107M | 4 mo ago | Series C | 40 | Mostafa ElSayed Co-Founder & CEO | WordPress Block EditorWordPressApple iCloud Mail+33 | — | 1 partnership |
| 4 | Causaly Provider of an AI platform for life sciences and biomedical research | $93M | 35 mo ago | Series B | 37 | Yiannis Kiachopoulos Co-Founder & CEO | WebflowApple iCloud MailGoogle Workspace+22 | — | — |
| 5 | Basecamp Research Biotechnology company using AI to explore undiscovered biology for applications in pharma, food, and industry 48AI top 20%Funding top 25%Talent top 38%Moat bottom 48% All 10 signals ▾AItop 20% Fundingtop 25% Talenttop 38% Moatbottom 48% Growthbottom 47% Techbottom 47% Partnersbottom 43% Newsbottom 41% Globalbottom 39% Marketbottom 27% AI: Classified as an AI company Funding: Raised $85.0M across 3 rounds · 3 rounds over 4 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 48/100 | $85M | 21 mo ago | Series B | 10 | Oliver Vince Co-Founder | WordPressApple iCloud MailMySQL+21 | — | 1 launch |
| 6 | Synthace Developer of software for automating biological experiments and data analysis | $80M | 55 mo ago | Series C | 68 68 → 36 (-47%) | Markus Gershater Co-Founder & CEO | HubSpot CMS HubApple iCloud MailGoogle Workspace+20 | 26 patents Automated laboratory and bioprocess workflows, including liquid handling and data integration. | — |
| 7 | Inpharmatica Developer of predictive informatics based platform for drug discovery | $75M | 111 mo ago | Acquired | 62 | John Lisle CEO | — | 15 patents Novel thiophene and pyrazole small‑molecule PPAR agonists for metabolic disorder therapeutics | — |
| 8 | LabGenius Manufacturer of synthetic DNA libraries | $73M | 24 mo ago | Series B | 54 | James Field CEO & Founder | — | 12 patents Protein engineering platforms and synthetic DNA assembly technologies for biotech development | — |
| 9 | Life Bit AI and SaaS-based genomics analysis software for drug development | $71M | 56 mo ago | Series B | 39 39 → 66 (+69%) | Pablo Barja Co-Founder & CTO | WordPressApple iCloud MailGoogle Workspace+28 | — | 5 partnerships |
| 10 | LabGenius Therapeutics Developer of an automated platform for therapeutic antibody discovery | $70M | 24 mo ago | Series B | — | James Field Founder & CEO | WordPressMySQLMariaDB+20 | — | 1 job opening · 1 partnership |
| 11 | Relation AI-based drug development tools for researchers 55Funding top 25%Talent top 28%AI top 30%Growth top 35% All 8 signals ▾Fundingtop 25% Talenttop 28% AItop 30% Growthtop 35% Moattop 36% Techbottom 43% Globalbottom 37% Marketbottom 27% Funding: Raised $65.3M across 5 rounds · 5 rounds over 5 yrs (1.0/yr) Talent: 4 named leaders on record · 4 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 55/100 | $65M | 6 mo ago | Seed | 12 | Jake Taylor-King Co-Founder & Chief Innovation Officer | Craft CMSApple iCloud MailGoogle Workspace+11 | — | 1 partnership · 1 award |
| 12 | Latentlabs Developer of generative AI models for programmable biology 60Funding top 25%AI top 30%Growth top 35%Moat top 40% All 8 signals ▾Fundingtop 25% AItop 30% Growthtop 35% Moattop 40% Talentbottom 49% Globalbottom 48% Techbottom 43% Marketbottom 40% Funding: Raised $50.0M across 2 rounds · 2 rounds over 1 yrs (2.0/yr) AI: Classified as an AI company · Product described with: generative ai rank vs industry peers · Fliar Intelligence Index 60/100 | $50M | 16 mo ago | Series A | — | Simon Kohl Founder & CEO | WordPressMySQLPHP+18 | — | — |
| 13 | uMotif Cloud-based application for patient engagement and care coordination | $35M | 48 mo ago | Series B | 43 43 → 98 (+128%) | Ben James Co-founder & Chief Design Officer | WordPress Block EditorWordPressMySQL+19 | 2 patents Animated graphical user interface rendering on display screens | 3 awards |
| 14 | PostEra AI based molecular designing software for drug discovery | $26M | 53 mo ago | Series A | 3 | Aaron Morris Co-Founder & CEO | — | — | — |
| 15 | Econic Biosciences Developer of a platform for the discovery and development of targeted therapies for cancer | $20M | 25 mo ago | Series B | 10 | Richard Koche Co-Founder | — | — | — |
| 16 | Techspert Leading expert network for healthcare and life sciences 60Funding top 29%Tech top 30%Growth top 32%Moat top 39% All 7 signals ▾Fundingtop 29% Techtop 30% Growthtop 32% Moattop 39% Talentbottom 49% Globalbottom 46% Marketbottom 42% Funding: Raised $18.1M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) Tech: 43 technologies across 5/8 capability areas · Cloud: Amazon Cloudfront, Amazon S3 rank vs industry peers · Fliar Intelligence Index 60/100 | $18M | 3 mo ago | Acquired | 53 53 → 71 (+34%) | David Holden Co-Founder & CEO | HubSpot CMS HubSalesforceBootstrap+25 | — | — |
| 17 | uMed Provider of platform facilitating patient data access for life science research | $17M | 35 mo ago | Series A | 11 | Matt Wilson Founder & CEO | WordPressMySQLPHP+26 | — | 1 job opening |
| 18 | IMU Biosciences Provider of immune discovery platform for precision medicines | $15M | 28 mo ago | Series A | — | Tom Hayday Co-Founder | WordPressMySQLPHP+14 | — | 1 partnership |
| 19 | Electric Twin AI-powered digital twin technology for research and clinical applications in the life sciences industry 60Growth top 15%News top 22%Funding top 33%Talent top 38% All 8 signals ▾Growthtop 15% Newstop 22% Fundingtop 33% Talenttop 38% AItop 45% Techtop 46% Globalbottom 32% Marketbottom 25% Growth: Fresh capital in last 24 mo News: 6 BI events in 12 mo (of 6 tracked, 1 types) · 6 high-value events (IPO/M&A/funding/contracts) in 12 mo rank vs industry peers · Fliar Intelligence Index 60/100 | $14M | 9 mo ago | Series A | — | Alex Cooper Co-Founder & CEO | Framer SitesYouTubeReact+21 | — | 2 awards |
| 20 | Vamstar Provider of AI solutions for commercial operations in the life sciences | $11M | 49 mo ago | Series A | 28 28 → 70 (+150%) | Praful Mehta Co-Founder and CEO | WordPressMySQLPHP+10 | — | 1 partnership |
| 21 | SyntheticGestalt Provider of AI-based cheminformatics platform for drug discovery | $11M | 56 mo ago | Series A | 7 | — | Node.jsThree.jsReact+16 | — | — |
| 22 | RwHealth Provider of an AI-based drug discovery platform | $10M | 24 mo ago | Deadpooled | 23 | Scott Fletcher CEO | — | — | — |
| 23 | Multiomic Health Developer of AI-based multi-omics platform for precision medicine | $9M | 37 mo ago | Seed | 6 | Robert Thong Co-Founder & Chief Executive Officer | — | — | — |
| 24 | Veratrak Supply chain management software for the pharma industry | $8M | 40 mo ago | Seed | 9 | Jason Lacombe Co-Founder & CEO | — | — | — |
| 25 | Rgrid Online platform for real-time research process automation and data management | $8M | 19 mo ago | Seed | 10 | Amber Hill Founder & CEO | TypeScriptZone.jsAngular+9 | — | — |
| 26 | SökerData Provider of biomarker database platform for clinical outcomes | $8M | 27 mo ago | Funding Raised | — | Elsa Zekeng Founder & CEO | — | — | — |
| 27 | Micrographia Bio Developer of an AI-enabled imaging systems for drug discovery | $8M | 45 mo ago | Seed | 7 | Julia Li Co-Founder & CEO | — | — | — |
| 28 | Ignota Labs AI-driven toxicity prediction tools for early-stage drug discovery scientists | $7M | 15 mo ago | Seed | 9 | Layla Hosseini-Gerami Co-Founder | — | — | 2 partnerships · 1 award |
| 29 | DaltonTx Developer of AI-enabled platforms for drug discovery and development 35Talent top 28%Funding top 40%AI top 45%Global bottom 48% All 6 signals ▾Talenttop 28% Fundingtop 40% AItop 45% Globalbottom 48% Techbottom 36% Marketbottom 25% Talent: 4 named leaders on record · 4 C-suite/founder profiles curated Funding: Raised $5.4M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 35/100 | $5M | 8 mo ago | Seed | — | Adrian Rossall Co-Founder & CTO | Framer SitesReactLenis+7 | — | — |
| 30 | Little Journey Provider of digital health solutions for pediatric healthcare 29Growth top 35%Funding top 36%Talent top 38%Product top 47% All 8 signals ▾Growthtop 35% Fundingtop 36% Talenttop 38% Producttop 47% Globalbottom 39% Techbottom 34% Marketbottom 19% Newsbottom 18% Growth: Fresh capital in last 24 mo Funding: Raised $5.2M across 5 rounds · 5 rounds over 5 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 29/100 | $5M | 11 mo ago | Series A | 1 | Chris Evans Co-Founder & CEO | HubSpot CMS HubApple iCloud MailMicrosoft 365+9 | — | 1 job opening · 1 award |
| 31 | TernaryTx Developer of computational platform for molecular glue discovery and design 24Talent top 38%Funding top 42%AI top 45%Global bottom 48% All 6 signals ▾Talenttop 38% Fundingtop 42% AItop 45% Globalbottom 48% Marketbottom 25% Techbottom 22% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $4.8M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 24/100 | $5M | 3 mo ago | Seed | — | Chris Tame Co-Founder & CEO | Tiiny HostAmazon Web ServicesPlausible+4 | — | 1 internship |
| 32 | Adsilico Provider of insilico trials using virtual patients to assess medical device safety | $5M | 27 mo ago | Seed | — | Alejandro Frangi Co-Founder | — | — | — |
| 33 | Entelo Bio Developer of single-cell isoform sequencing platform for disease research 42Talent top 38%Funding top 47%Global bottom 48% All 3 signals ▾Talenttop 38% Fundingtop 47% Globalbottom 48% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $4.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 42/100 | $4M | 1 mo ago | Series A | — | Adam Cribbs Co-Founder & CTO | — | — | 1 launch · 1 partnership · 1 award |
| 34 | Evariste AI-based drug discovery platform to target synthetic lethal pathways in oncology | $4M | 33 mo ago | Seed | 9 | Anna Hercot CEO | Webflow EcommerceWebflowCloudflare Turnstile+11 | — | — |
| 35 | Simple Pharma Licensed pharmaceutical wholesaler providing end-to-end distribution and regulatory compliance services | $4M | 38 mo ago | Funding Raised | 21 | Nicolas Vennin Co-Founder | WebflowZohocore-js+15 | — | — |
| 36 | Kuano Technologies Provider of AI and quantum services for molecular design | $4M | 33 mo ago | Seed | 4 | David Wright Co-Founder & CTO | Cart FunctionalitySquarespace CommerceSquarespace+10 | 10 patents AI-driven small-molecule drug discovery and quantum/tensor network chemical modeling | — |
| 37 | Stitch Health Developer of a platform for clinical trial participant engagement and compliance | $3M | 45 mo ago | Seed | 4 | Mike Sterling Co-Founder and COO | SanityNode.jsReact+6 | — | — |
| 38 | ConcR Provider of a platform predicting therapeutic response and outcome for cancer | $3M | 33 mo ago | Seed | 6 | Matt Foster CEO | Craft CMSPHPYii+11 | — | 1 partnership |
| 39 | Gibran Platform offering AI research and development solutions 45AI top 20%Talent top 28%Growth top 35%Funding bottom 48% All 7 signals ▾AItop 20% Talenttop 28% Growthtop 35% Fundingbottom 48% Globalbottom 45% Techbottom 29% Marketbottom 25% AI: Classified as an AI company Talent: 4 named leaders on record · 4 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 45/100 | $3M | 9 mo ago | Seed | — | Govind Balakrishnan Co-Founder | Google Font APIGoDaddyCloudflare Bot Management+2 | — | — |
| 40 | Sable Bio AI-powered platform for drug safety prediction within the pharmaceutical industry 32Talent top 38%Funding top 44%AI top 45%Moat top 48% All 7 signals ▾Talenttop 38% Fundingtop 44% AItop 45% Moattop 48% Techbottom 45% Globalbottom 32% Marketbottom 28% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $1.9M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 32/100 | $2M | 9 mo ago | Seed | — | Josh Almond-Thynne Co-Founder | Framer SitesReactAmazon Web Services+10 | — | 1 partnership |
| 41 | ValueBase Provider of pharmaceutical and healthcare business intelligence solution | $2M | 40 mo ago | Seed | 18 18 → 21 (+17%) | Karen Westaway CEO | — | — | — |
| 42 | PolyModels Hub Provider of a platform to accelerate drug development 29Talent top 28%News top 32%Funding top 43%Moat top 48% All 7 signals ▾Talenttop 28% Newstop 32% Fundingtop 43% Moattop 48% Techbottom 48% Globalbottom 37% Marketbottom 28% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated News: 3 BI events in 12 mo (of 4 tracked, 2 types) · +200% YoY rank vs industry peers · Fliar Intelligence Index 29/100 | $1M | 6 mo ago | Series A | — | Antonio Yankey Co-Founder | ContentfulApple iCloud MailGoogle Workspace+14 | — | 1 launch |
| 43 | New Wave Biotech Provider of AI downstream process optimization software for biotech industry | $1M | 18 mo ago | Seed | — | Oli Hall Co-Founder | — | — | — |
| 44 | Verisian Developer of clinical trial analysis solutions using traceability and AI | $1M | 33 mo ago | Seed | — | Henning Kuich Co-Founder and CTO | WebflowHubSpotcore-js+14 | — | — |
| 45 | Briefly Platform to capture and share lab work reproducibly | $1M | 23 mo ago | Seed | — | Katya Putintseva Co-Founder | — | — | — |
| 46 | Klaris Provider of AI-powered compliance solutions for medical device manufacturers 27Talent top 38%AI top 45%Funding bottom 47%Global bottom 45% All 6 signals ▾Talenttop 38% AItop 45% Fundingbottom 47% Globalbottom 45% Techbottom 39% Marketbottom 25% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated AI: Product described with: ai-powered rank vs industry peers · Fliar Intelligence Index 27/100 | $1M | 4 mo ago | Seed | — | Mihai Sorin Co-Founder & CTO | Apple iCloud MailGoogle WorkspaceGoogle Cloud+7 | — | — |
| 47 | Giles Developer of an AI agent for medical and healthcare research | $946K | 12 mo ago | Seed | — | Constantin Gorgan Co-Founder | WordPressMySQLPHP+28 | — | 1 launch |
| 48 | PentaBind AI-based molecular modeling and aptamers designing tool for diagnostics | $682K | 29 mo ago | Seed | 4 | Phil Haynes Co-Founder & CTO | Wix eCommerceWixSentry+17 | — | — |
| 49 | Metofico Developer of no code data analysis tools for life science researchers | $500K | 24 mo ago | Seed | — | Mehdi Boudjadja Co-Founder & CEO | — | — | — |
| 50 | AminoAnalytica AI-based protein-based therapeutics drug discovery platform | $125K | 23 mo ago | Seed | — | Abhi Rajendran Co-Founder | — | — | — |
Top 12 Life Sciences Tech companies in London
#1
Series B · London, England · founded 2021$2.7Braised▾
Series B · London, England · founded 2021
Digital platform focused on revolutionizing drug discovery using AI. The company's computational tools analyze complex biological phenomena to assist in the design of molecules. The technology predicts how potential therapeutic compounds perform to facilitate the development of treatments for various diseases.
Fliar Intelligence Index™ 60how this company ranks against its industry peers
Funding
top 12%AI
top 20%Innovation
top 30%Patents
top 33%Moat
top 39%Talent
bottom 49%Funding: Raised $2.7B across 2 rounds · 2 rounds over 1 yrs (2.0/yr) · Last round Series B (May 2026)
AI: Classified as an AI company
Innovation: 19 patents (top 47% of patent-holders) · 19 filings since 2022 vs 0 in 2017-21 · Deep-tech classification: Artificial Intelligence
Audience (LinkedIn): 95k LinkedIn followers — 21.4% of this cohort's audience
Funding rounds
- May 2026Series B$2.1B
- Mar 2025Series A$600M
Founders & team
Investors
Thrive Capital, Google Ventures, Alphabet, MGX, Temasek, CapitalG
Tech stack
<Model-Viewer>CloudflareCookiebotGoogle AnalyticsGoogle Hosted LibrariesGsap
#2
Series C · London, England · founded 2015 · 40 employees$106.5Mraised▾
Series C · London, England · founded 2015 · 40 employees
Developer of modular lab automation platforms for biological research workflows. This system integrates hardware and software to orchestrate laboratory processes, including sample handling and instrument management. The platform utilizes node-based design tools and software development kits to enable workflow configuration and simulation. It supports connectivity with external data systems and analytical models to facilitate automated execution of experimental protocols. The hardware components are configurable to accommodate various instruments and laboratory layouts, allowing for the management of multiple concurrent tasks.
Fliar Intelligence Index™ 64how this company ranks against its industry peers
Funding
top 25%Product
top 25%Tech
top 27%Moat
top 31%Innovation
top 32%Fin. health
top 33%Funding: Raised $107M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) · Last round Series C (Jan 2026)
Product: 7 distinct product lines · Company stage: Series C
Tech: 55 technologies across 6/8 capability areas · Cloud: Amazon S3, Amazon Web Services · Devops: Varnish
Audience (LinkedIn): 19k LinkedIn followers — 4.3% of this cohort's audience
Activity (LinkedIn): 1 partnerships (incl. Automata) announced in 12 mo
Funding rounds
- Jan 2026Series C$45M
- Oct 2023Series B$40M
- Feb 2022Series B$50M
- Mar 2019Series A$7.4M
Founders & team
Investors
Dimension, Octopus Ventures, Hummingbird Ventures, Isomer Capital, Possible Ventures, Aldea Ventures
Tech stack
Amazon Web ServicesApple Icloud MailClickceaseCloudflareCloudflare Bot ManagementCookiebot
#3
Seed · London, England · founded 2019 · 12 employees$65.3Mraised▾
Seed · London, England · founded 2019 · 12 employees
AI-based drug development tools for researchers. The company has developed software for target and drug discovery. The platform leverages human genetics, single-cell omics, and perturbational data for genetic disease management.
Fliar Intelligence Index™ 55how this company ranks against its industry peers
Funding
top 25%Talent
top 28%AI
top 30%Growth
top 35%Moat
top 36%Tech
bottom 43%Funding: Raised $65.3M across 5 rounds · 5 rounds over 5 yrs (1.0/yr) · Last round Seed (Nov 2025)
Talent: 4 named leaders on record · 4 C-suite/founder profiles curated
AI: Classified as an AI company · Product described with: ai-based
Audience (LinkedIn): 16k LinkedIn followers — 3.6% of this cohort's audience
Activity (LinkedIn): 1 partnerships · 1 awards (incl. Novatis) announced in 12 mo
Funding rounds
- Nov 2025Seed$36.2M
- Nov 2024Seed$15M
- Jan 2024Seed$40.3M
- May 2022Seed$16M
Founders & team
Investors
DCVC, Magnetic Ventures, OMERS, Khosla Ventures, Firstminute Capital, ARK Investment Management
Tech stack
Apple Icloud MailCloudflareCraft CmsGoogle WorkspaceGsapHsts
#4
Acquired · London, England · founded 2016 · 53 employees$18.1Mraised▾
Acquired · London, England · founded 2016 · 53 employees
Leading expert network for healthcare and life sciences. Platform connecting healthcare and life science organizations with subject matter experts. It facilitates primary research by providing access to a network of professionals. The platform offers tools for expert identification, interview scheduling, and automated call analysis. It also provides features for data capture, transcript access, and quote sharing.
Fliar Intelligence Index™ 60how this company ranks against its industry peers
Funding
top 29%Tech
top 30%Growth
top 32%Moat
top 39%Talent
bottom 49%Global
bottom 46%Funding: Raised $18.1M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) · Last round PE (Feb 2026)
Tech: 43 technologies across 5/8 capability areas · Cloud: Amazon Cloudfront, Amazon S3 · Observability: Sentry
Growth: Headcount 39 → 53 (+36%) across vintages · Fresh capital in last 24 mo
Audience (LinkedIn): 7k LinkedIn followers
Funding rounds
- Feb 2026PE$6.7M
- Oct 2021Series B$12M
- Feb 2020Unattributed$4.9M
- Dec 2018Unattributed$1.3M
Founders & team
Investors
ACF Investors, BGF, Nauta Capital, Cambridge Angels, Palatine Private Equity, Martlet Capital
Tech stack
Amazon CloudfrontAmazon S3Amazon Web ServicesBootstrapCdnjsCloudflare
#5
Series A · London, England · founded 2023$4Mraised▾
Series A · London, England · founded 2023
Developer of single-cell isoform sequencing platform for disease research. This platform reveals hidden biological information to facilitate the development of transformative therapies for chronic diseases. The technology offers unmatched resolution in decoding disease complexity, leading to a deeper understanding of disease mechanisms and potential treatment strategies. The platform is designed to provide researchers with detailed insights into cellular heterogeneity and gene expression patterns.
Fliar Intelligence Index™ 42how this company ranks against its industry peers
Talent
top 38%Funding
top 47%Global
bottom 48%Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Funding: Raised $4.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Series A (Apr 2026)
Global: Investors from 1 country beyond United Kingdom
Audience (LinkedIn): 2k LinkedIn followers
Activity (LinkedIn): 1 product launches · 1 partnerships · 1 awards (incl. Atrogi) announced in 12 mo
Funding rounds
- Apr 2026Series A$4M
Founders & team
Investors
Ananda Impact Ventures, Creator Fund
#6
Seed · London, England · founded 2024$4.8Mraised▾
Seed · London, England · founded 2024
Developer of computational platform for molecular glue discovery and design. The platform identifies protein surface hotspots for ternary complex formation using proprietary models. It prioritizes virtual effector proteins, enabling mechanism deconvolution. The technology facilitates computational discovery of targetable binding sites using simulations. It also offers a glue-specific virtual screening platform using artificial intelligence methods.
Fliar Intelligence Index™ 24how this company ranks against its industry peers
Talent
top 38%Funding
top 42%AI
top 45%Global
bottom 48%Market
bottom 25%Tech
bottom 22%Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Funding: Raised $4.8M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Seed (Mar 2026)
AI: Product described with: artificial intelligence
Audience (LinkedIn): 3k LinkedIn followers
Funding rounds
- Mar 2026Seed$4.8M
- Feb 2025Seed—
Founders & team
Investors
Pace Ventures, i&i Bio, Daphni, Future Planet Capital
Tech stack
Amazon CloudfrontAmazon S3Amazon Web ServicesGoogle Font ApiOpen GraphPlausible
#7
Series A · London, England · founded 2020$13.8Mraised▾
Series A · London, England · founded 2020
AI-powered digital twin technology for research and clinical applications in the life sciences industry. It construct synthetic populations and bespoke personas mirroring real demographic that can be used by researchers to better understand patient populations, develop more effective treatments, and improve clinical trial design.
Fliar Intelligence Index™ 60how this company ranks against its industry peers
Growth
top 15%News
top 22%Funding
top 33%Talent
top 38%AI
top 45%Tech
top 46%Growth: Fresh capital in last 24 mo
News: 6 BI events in 12 mo (of 6 tracked, 1 types) · 6 high-value events (IPO/M&A/funding/contracts) in 12 mo · Top themes: Funding
Funding: Raised $13.8M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) · Last round Series A (Sep 2025)
Audience (LinkedIn): 3k LinkedIn followers
Activity (LinkedIn): 2 awards announced in 12 mo
Funding rounds
- Sep 2025Series A$10M
- Jan 2024Series A$3.8M
Founders & team
Investors
Mercuri, Atomico, LocalGlobe, Samos Investments
Tech stack
Amazon Web ServicesCloudflareCloudflare Bot ManagementContentsquareCookiebotCore-Js
#8
Series A · London, England · founded 2020$50Mraised▾
Series A · London, England · founded 2020
Developer of generative AI models for programmable biology. It provides a platform for designing new antibodies, optimizing existing enzymes, and advancing genetic engineering. It focuses on creating frontier models to capture the fundamentals of biology. It offers tools for protein binder design through its platform. It enables the creation of new proteins, transforming biology into a programmable and engineering discipline.
Fliar Intelligence Index™ 60how this company ranks against its industry peers
Funding
top 25%AI
top 30%Growth
top 35%Moat
top 40%Talent
bottom 49%Global
bottom 48%Funding: Raised $50.0M across 2 rounds · 2 rounds over 1 yrs (2.0/yr) · Last round Series A (Feb 2025)
AI: Classified as an AI company · Product described with: generative ai
Growth: Fresh capital in last 24 mo
Audience (LinkedIn): 11k LinkedIn followers — 2.5% of this cohort's audience
Activity (LinkedIn): 1 product launches announced in 12 mo
Funding rounds
- Feb 2025Series A$40M
- Seed$10M
Founders & team
Investors
Radical Ventures, Sofinnova Partners, Flying Fish Ventures, Isomer Capital, 8VC, Kindred Capital
Tech stack
Amazon SesAmazon Web ServicesCloudflareCloudflare Bot ManagementContact Form 7Cookiebot
#9
Seed · London, England · founded 2024$1.2Mraised▾
Seed · London, England · founded 2024
Provider of AI-powered compliance solutions for medical device manufacturers. The platform ensures maximum impact, streamline regulatory processes integration, and compliance, aiding regulated industries in navigating complex regulatory landscapes.
Fliar Intelligence Index™ 27how this company ranks against its industry peers
Talent
top 38%AI
top 45%Funding
bottom 47%Global
bottom 45%Tech
bottom 39%Market
bottom 25%Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
AI: Product described with: ai-powered
Funding: Raised $1.2M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) · Last round Seed (Feb 2026)
Audience (LinkedIn): 550 LinkedIn followers
Funding rounds
- Feb 2026Seed$1M
- Apr 2025Seed—
- Dec 2024Seed$151.4K
Founders & team
Investors
Antler, Meridian Health Ventures, Vento, Alecla7, Mainspring Fund Services
Tech stack
Apple Icloud MailAstroGodaddyGoogle CloudGoogle Cloud StorageGoogle Font Api
#10
Seed · London, England · founded 2024$5.4Mraised▾
Seed · London, England · founded 2024
Developer of AI-enabled platforms for drug discovery and development. The company's technology integrates into scientific workflows, learns from experiments, and accelerates medicine creation. It offers adaptive systems combining machine learning, software engineering, and drug discovery expertise. The platforms are purpose-built for both small molecules and biologics.
Fliar Intelligence Index™ 35how this company ranks against its industry peers
Talent
top 28%Funding
top 40%AI
top 45%Global
bottom 48%Tech
bottom 36%Market
bottom 25%Talent: 4 named leaders on record · 4 C-suite/founder profiles curated
Funding: Raised $5.4M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Seed (Sep 2025)
AI: Product described with: machine learning
Funding rounds
- Sep 2025Seed$5.4M
Founders & team
Investors
Redalpine, Seedcamp, IQ Capital, Oxford University Innovation
Tech stack
Framer SitesGodaddyGoogle Font ApiHstsHttp/3Lenis
#11
Series B · London, England · founded 2019 · 10 employees$85Mraised▾
Series B · London, England · founded 2019 · 10 employees
Biotechnology company using AI to explore undiscovered biology for applications in pharma, food, and industry These models utilize large-scale genetic datasets to generate protein sequences for medical applications. The technology enables the creation of genetic medicines and therapeutic agents by applying computational analysis to evolutionary biological data. This approach facilitates the design of molecules for various disease areas and biological functions.
Fliar Intelligence Index™ 48how this company ranks against its industry peers
AI
top 20%Funding
top 25%Talent
top 38%Moat
bottom 48%Growth
bottom 47%Tech
bottom 47%AI: Classified as an AI company
Funding: Raised $85.0M across 3 rounds · 3 rounds over 4 yrs (0.8/yr) · Last round Series B (Sep 2024)
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Audience (LinkedIn): 17k LinkedIn followers — 3.9% of this cohort's audience
Activity (LinkedIn): 1 product launches announced in 12 mo
Funding rounds
- Sep 2024Series B$60M
- Aug 2022Series A$20M
- Aug 2021Series A$5.7M
Founders & team
Investors
SYSTEMIQ, Valo Health, Blue Horizon, True Ventures, Hummingbird Ventures, Singular
Tech stack
Amazon Web ServicesApple Icloud MailCloudflareCloudflare Bot ManagementComplianzCore-Js
#12
Series A · London, England · founded 2018 · 1 employees$5.2Mraised▾
Series A · London, England · founded 2018 · 1 employees
Provider of digital health solutions for pediatric healthcare. It offers a platform to prepare and support children and families during healthcare interactions, enhancing experiences and outcomes. The solutions are tailored for clinical trials, hospitals, and individual patients and families, utilizing an app for access. The platform aims to eliminate anxiety and enhance the healthcare journey for young patients.
Fliar Intelligence Index™ 29how this company ranks against its industry peers
Growth
top 35%Funding
top 36%Talent
top 38%Product
top 47%Global
bottom 39%Tech
bottom 34%Growth: Fresh capital in last 24 mo
Funding: Raised $5.2M across 5 rounds · 5 rounds over 5 yrs (1.0/yr) · Last round Series A (Jul 2025)
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Audience (LinkedIn): 9k LinkedIn followers — 2.1% of this cohort's audience
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Marketing Campaigns & Operations Manager
Activity (LinkedIn): 1 awards announced in 12 mo
Funding rounds
- Jul 2025Series A$402.1K
- Nov 2024Grant (prize money)$4M
- Sep 2024Series A$7.6M
- Aug 2022Series A$3.1M
Founders & team
Investors
Mercia, Octopus Ventures, Northern Powerhouse, Calm/Storm, Learningthroughplay, SBRI Healthcare
Tech stack
Apple Icloud MailCloudflareCloudflare Bot ManagementCore-JsGodaddyHsts
Funding & investor landscape
$3.9Btotal disclosed funding
77companies funded
169disclosed rounds
2rounds last 90 days
Most active investors
Notable founders
Demis Hassabis
Founder & CEO · Isomorphic Labs
Mostafa ElSayed
Co-Founder & CEO · Automata
Jake Taylor-King
Co-Founder & Chief Innovation Officer · Relation
Charles Roberts
Co-Founder · Relation
David Holden
Co-Founder & CEO · Techspert
Adam Cribbs
Co-Founder & CTO · Entelo Bio
Peter Crane
Co-Founder & CEO · Entelo Bio
Chris Tame
Co-Founder & CEO · TernaryTx
Andrew Potterton
Co-Founder & CTO · TernaryTx
Alex Cooper
Co-Founder & CEO · Electric Twin
Ben Warner
Co-Founder · Electric Twin
Simon Kohl
Founder & CEO · Latentlabs
Prism market signals · United Kingdom · country-scoped Prism corpus, 3,727,682 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH IN LONDON · Health & Bio
How research on Biotechnology in London is moving
A read on the academic research around Biotechnology in London — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 246 papers.
London's Imperial College, UCL, and King's College drive predominantly recent (193 post-2020) biotechnology research across RNA splicing, CRISPR, and malaria, with an optimistic breakthrough-led stance (0.42).
246 papers · stance +0.42 · 40% breakthrough · 21% concern
top institutions
- Imperial College London70
- University College London67
- King\'s College London41
- London School of Hygiene & Tropical Medicine28
- Queen Mary University of London22
leading researchers
Beatriz Sanchez-Pintado · Emily R. Eden · Farah Olivia Rezek · Julio C. Corral-Serrano · Nancy Aychoua · Carina Graham
prism intelligence · tone & topics
89% positive · 6% critical tone
HealthMedical ResearchPharmaceuticalsGeneticsBiologyClinical Trials
▲
Breakthroughs81 · 33%
▼ 36%→33% share
▼0.9× share momentum0 median citations79% since 2021mostly empirical
Gene editing research newly dominates Breakthroughs at 8 papers, while Chromatin and Antibody topics each quadrupled since baseline.
rising sub-themes (early→recent)
- Chromatin1→4
- Antibody1→4
Newly emergingGene 0→8 · Oligonucleotide 0→5 · Mutation 0→5
Landmark Biomedical photoacoustic imaging · 2,130 cites
◆
Advancements77 · 31%
▲ 19%→34% share
▲1.8× share momentum0 median citations86% since 2021mostly empirical
Advancements field-share nearly doubled (19%→34%), led by newly emerging Gene (8) and Antimicrobial (6) research clusters.
rising sub-themes (early→recent)
- Messenger RNA1→3
Newly emergingGene 0→8 · Antimicrobial 0→6 · Cell culture 0→4
Landmark Characterization of a Novel, Water-Soluble Hydrogen Sulfide–Releasing Molecule (GYY4137) · 824 cites
▼
Concerns42 · 17%
▼ 23%→15% share
▼0.7× share momentum0 median citations67% since 2021mostly reviews
Antibiotic resistance research tripled as Concerns field-share shrinks (23%→15%), signalling intensifying focus within a contracting segment.
rising sub-themes (early→recent)
- Antibiotic resistance1→3
Newly emergingAntimicrobial 0→3 · Drug resistance 0→3 · Malaria 0→3
Landmark Top 10 plant pathogenic bacteria in molecular plant pathology · 2,329 cites
Common questions
How many Life Sciences Tech companies are there in London, United Kingdom?
Radar tracks 169 indexable Life Sciences Tech companies headquartered in London, United Kingdom that meet our profile-completeness bar.
What is the total funding raised by Life Sciences Tech companies in London, United Kingdom?
The Life Sciences Tech companies in London, United Kingdom on this list have raised a combined $3.9B in disclosed equity funding across 77 funded companies.
Which is the highest-funded Life Sciences Tech company in London, United Kingdom?
Isomorphic Labs is the highest-funded Life Sciences Tech company in London, United Kingdom, with $2.7B in disclosed equity funding.
How many Life Sciences Tech companies in London, United Kingdom are funded?
77 of the 169 Life Sciences Tech companies in London, United Kingdom on this list have disclosed at least one equity funding round.
How many Life Sciences Tech unicorns are there in London, United Kingdom?
None of the Life Sciences Tech companies in London, United Kingdom on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in London, United Kingdom Life Sciences Tech companies?
The most active investors in London, United Kingdom Life Sciences Tech companies on this list include Entrepreneur First, P4, Y Combinator, Mainspring Fund Services, Europa.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.